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XPR1 is the only known metazoan
exporter for inorganic phosphate, a
crucial ion necessary for bonemineraliza-
tion and diverse cellular activities. Meir-
eles et al. now identify null mutations in
xpr1a and xpr1b, the zebrafish orthologs
of human XPR1. Zebrafish xpr1bmutants
lack microglia and other tissue-resident
macrophage populations but display no
gross developmental defects, and
xpr1a;xpr1b double mutants have a
similar phenotype. This genetic analysis
reveals a specific role for Xpr1b in the dif-
ferentiation of tissue macrophages.
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Phosphate concentration is tightly regulated at the
cellular and organismal levels. The first metazoan
phosphate exporter, XPR1, was recently identified,
but its in vivo function remains unknown. In a genetic
screen, we identified a mutation in a zebrafish ortho-
log of human XPR1, xpr1b. xpr1b mutants lack
microglia, the specialized macrophages that reside
in the brain, and also displayed an osteopetrotic
phenotype characteristic of defects in osteoclast
function. Transgenic expression studies indicated
that xpr1b acts autonomously in developing macro-
phages. xpr1b mutants display no gross develop-
mental defects that may arise from phosphate imbal-
ance. We constructed a targeted mutation of xpr1a,
a duplicate of xpr1b in the zebrafish genome, to
determine whether Xpr1a and Xpr1b have redundant
functions. Single mutants for xpr1a were viable, and
double mutants for xpr1b;xpr1a were similar to
xpr1b single mutants. Our genetic analysis reveals
a specific role for the phosphate exporter Xpr1 in
the differentiation of tissue macrophages.
INTRODUCTION
Macrophages are a highly diverse population of immune cells
present in virtually all tissues of vertebrates. Macrophages are
important for not only phagocytosis and immune system regu-
lation but also tissue homeostasis and development (Davies
et al., 2013; Wynn et al., 2013). For example, besides their
well-known role in the immune defense of the CNS, microglial
cells (brain-resident macrophages) are also important for clear-
ance of cellular debris and regulating neuronal connectivity
(Paolicelli et al., 2011; Peri and Nu¨sslein-Volhard, 2008; Ran-
sohoff and Cardona, 2010; Schafer et al., 2012). Similarly, oste-
oclasts (bone-resorbing macrophages) are essential for correct
bone development, bone remodelling in adults, and mineral
homeostasis at the organismal level. Mice that are devoid of os-
teoclasts develop osteopetrosis, a condition characterized by
abnormal bone structure and altered hematopoiesis (Begg
et al., 1993; Pollard, 1997). Despite the importance of tissue
macrophages, the mechanisms that control the developmentCell Reand dedicated functions of tissue macrophages are not well
understood.
Inorganic phosphate (Pi) is a crucial ion necessary for bone
mineralization and diverse cellular activities, because it forms
an integral part of membrane phospholipids, nucleic acids, and
ATP. Furthermore, phosphate has an important role in many
signaling pathways involving kinases and phosphatases (Biber
et al., 2013; Forster et al., 2013). SLC34 and SLC20 are trans-
porters that define two classes of molecules that import phos-
phate into cells. SLC34 family members are expressed and
localized in the apical membrane of enterocytes (NPT2b/
SLC34A2) and epithelial cells of the proximal tubule in the kidney
(NPT2a/SLC34A1). Members of SLC20 family are ubiquitously
expressed and are considered to be suppliers of phosphate for
cellular metabolism and bone mineralization (Biber et al., 2013;
Forster et al., 2013). Although the existence of a dedicated phos-
phate exporter has long been hypothesized, the first metazoan
phosphate exporter, XPR1, was only recently identified (Giovan-
nini et al., 2013).
XPR1 is a highly conserved multipass transmembrane protein
originally identified as a receptor for xenotropic and polytropic
murine retroviruses (Battini et al., 1999; Tailor et al., 1999;
Yang et al., 1999). XPR1 possesses two characteristic protein
domains: SPX (named after the proteins Syg1, Pho81, and
XPR1) and EXS (named after the proteins ERD, XPR1 and
Syg1). The SPX domain is conserved throughout evolution
and present in many yeast and plant proteins involved in phos-
phate homeostasis (Secco et al., 2012a, 2012b). The SPX
domain of XPR1 is dispensable for phosphate export and viral
infection (Giovannini et al., 2013; Wege and Poirier, 2014).
Because overexpression of XPR1 or of a truncated form contain-
ing the SPX domain leads to an increase in intracellular cyclic
AMP levels (Vaughan et al., 2012), and because XPR1 interacts
with the Gb subunit of the G protein trimer, this protein has
also been classified as an atypical G protein-coupled receptor
(Vaughan et al., 2012). Despite the evidence for a role in phos-
phate export and its potential role as a transmembrane receptor,
XPR1 may also have other activities, and there is little under-
standing of its function in vivo.
xpr1a and xpr1b are the zebrafish orthologs of XPR1. In this
study, we show that the phosphate exporter xpr1b acts specif-
ically in macrophages to promote the differentiation and estab-
lishment of several tissue-resident macrophage populations.
xpr1b mutants lack microglia and also have a reduction in the
number and complexity of Langerhans cells. Furthermore, weports 8, 1659–1667, September 25, 2014 ª2014 The Authors 1659
Figure 1. xpr1b Is Required Autonomously
in Macrophages for Microglia Development
(A) The 5 dpf zebrafish larvae were stained with the
microglial vital marker neutral red (Herbomel et al.,
2001). Left panel shows the dorsal view of xpr1b
heterozygous larva with microglia (arrow) in the
optic tectum.
(B)Whole-mount in situhybridizationat 5dpf reveals
the expression of the microglial marker apoe in
xpr1b heterozygous larva, but not in xpr1bmutants.
(C) Lateral view of neutral red-stained heterozy-
gous and homozygous mutants shows normal
whole-animal morphologies at 5 dpf.
(D) Schematic representation of the st87 locus.
(E) Chromatogram depicts the lesion (arrow) in the
coding sequence of xpr1b.
(F) Graphical representation of the domain struc-
ture of Xpr1 and the location of the st87 lesion
(asterisk).
(G) Diagram represents the transgenic constructs
driving the expression of mcherry reporter or wild-
type xpr1b under the control of macrophage
(mpeg1), neurons (huC), or neutrophils (lyz) tissue
promoters. Below are representative images of
neutral red-stained xpr1b mutant fish expressing
mcherry (left) or xpr1b (right) under the macro-
phage lineage-specific promoter. Microglia are
present only when xpr1b is expressed under the
mpeg1 promoter.
(H) Graph shows the percentage of mutants
rescued by different tissue-specific promoters.
The number of embryos analyzed for each condi-
tion, mCherry (C) or xpr1b, is shown below.
Scale bar, 50 mm. See also Figure S1.demonstrate that xpr1b mutants have profound defects in bone
architecture characteristic of osteoclast disruption. Additionally,
our genetic analysis of xpr1a, the only additional zebrafish pa-
ralog of xpr1b, showed that xpr1a mutants had no defects in
microglia formation and that xpr1b; xpr1a double mutants are
phenotypically similar to xpr1b mutants. Thus, our genetic anal-
ysis provides evidence that the macrophage lineage is particu-
larly sensitive to alterations in Xpr1 function.
RESULTS
Genetic Screen Identifies xpr1b as a Regulator of
Macrophage Development
We conducted a genetic screen for N-ethyl-N-nitrosourea
(ENU)-inducedmutations causing abnormalities in microglia, us-
ing the vital dye neutral red, a previously reportedmarker of mac-
rophages and microglia in zebrafish (Herbomel et al., 2001). This
screen identified xpr1bst87 as a mutation that severely reduced
the number of neutral red-labeled microglia (Figures 1A). At
5 days postfertilization (dpf), homozygous xpr1bst87 mutant
larvae lacked expression of the microglial marker apolipopro-
teine (apoe) (Herbomel et al., 2001; Peri and Nu¨sslein-Volhard,
2008) (Figure 1B) but were otherwise morphologically indistin-
guishable from wild-type and heterozygous siblings (Figure 1C).
High-resolution genetic mapping placed the xpr1bst87 mutation
in a 0.64 Mb region of linkage group 2 (LG2) that contains the
xpr1b gene (Figure 1D). Xpr1b shares 79% identity and 87%sim-1660 Cell Reports 8, 1659–1667, September 25, 2014 ª2014 The Auilarity with the human XPR1 protein, which was originally identi-
fied as a retroviral receptor (Battini et al., 1999; Tailor et al., 1999;
Yang et al., 1999) and has been recently characterized as
an inorganic phosphate exporter (Giovannini et al., 2013).
Sequence analysis of xpr1bst87 mutants identified a T to A trans-
version that introduces a premature stop codon near the 50 end
of xpr1b open reading frame (Figure 1E). All xpr1bst87 mutants
analyzed were homozygous for this lesion (n = 80). To obtain
additional evidence that xpr1b is disrupted by the xpr1bst87
mutation, we rescued the mutants by injecting synthetic mRNA
encoding wild-type xpr1b. Injection of 200 pg of xpr1b mRNA
into xpr1bst87 mutants rescued the microglia phenotype (Fig-
ure S1A). Furthermore, we also generatedmutations in xpr1b us-
ing sequence-specific transcription activator-like effector (TALE)
nucleases (Sanjana et al., 2012; Christian et al., 2010). We iso-
lated two frameshift mutations, namely xpr1bst89 and xpr1bst90.
Both mutations failed to complement xpr1bst87, and homozy-
gous xpr1bst89 and xpr1bst90mutants also lacked microglial cells
(Figure S1B). Taken together, the mapping, analysis of two other
mutant alleles, and rescue experiments demonstrate that
xpr1bst87 is a loss-of-function mutation in the xpr1b gene.
xpr1b Is Required Autonomously in Macrophages for
Microglia Development
To test whether Xpr1b is required autonomously in the macro-
phage lineage or in other cell types, we employed a transgenic
rescue strategy. Coding sequences for xpr1b or the reporterthors
Figure 2. xpr1b Is Required for Brain Colo-
nization by Microglial Progenitors
(A and B) Representative z-projections of mpe-
g1:EGFP-labeled cells at 2–4 dpf in the head (A) or
4 dpf in the trunk (B), in heterozygous larvae (top
panel), or in xpr1b mutants (lower panel).
(C–E) Graphs show the average number of mpe-
g1:EGFP-positive cells in the highlighted region of
fish schematics: CNS (eye, midbrain and hind-
brain) (C), head periphery (D), and trunk (E). xpr1b
mutants show a reduction in the average number
of macrophages in the CNS region starting at 2
dpf. Error bars show SEM. Statistical significance
was determined by paired two-tailed Student’s
test (*p % 0.05, **p % 0.01, ***p % 0.001; 2 dpf:
mutants n = 7, siblings n = 16; 3 dpf: mutants n = 6,
siblings n = 16; 4dpf: mutants n = 4, siblings n = 9).
(F) Whole-mount in situ hybridization at 2 and 3 dpf
shows mfap4+ macrophages in the brain of wild-
type heterozygous (top panel) larva, but not in
xpr1b mutants (lower panel).
(G) Whole-mount in situ hybridization at 3 dpf
shows apoe+ microglia in the brain of wild-type
heterozygous (top panel) larva, but not in xpr1b
mutants (lower panel).
(H) Serial single-plane images of stable trans-
genic fish expressing the macrophage marker
mpeg1:EGFP and the vasculature marker
kdrl:mCHERRYCAAX. Images show extensive
penetration of macrophages into the brain of wild-
type heterozygous fish (top panels) and only a few
in xpr1b mutants (lower panels) (arrowheads indi-
cate macrophages).
(I) z stack images of stable transgenic fish ex-
pressing the microglia marker apoe:EGFP. Im-
ages show microglia cells with processes in
wild-type fish at 5 and 10 dpf (top panels),
whereas no microglia cells are present in xpr1b
mutants, even at 10 dpf (right panel).
Scale bar, 50 mm. See also Figures S2 and S3 and
Movies S1, S2, S3, and S4mCherry were expressed under the control of cell-specific regu-
latory elements that drive expression in neurons (elavl3/huC),
neutrophils (lyz), or macrophages (mpeg1) as previously
described (Shiau et al., 2013). Transient Tol2-mediated expres-
sion of the wild-type xpr1b gene under the control ofmpeg1 reg-
ulatory elements rescued microglia (>15 cells/embryo) in 67% of
xpr1bmutants (n = 28). There was no significant rescue of micro-
glia when xpr1b gene was expressed in other cell types or by
expression of themCherry coding sequence in any cell type (Fig-
ures 1G and 1H). These data indicate that xpr1b is required in the
macrophage lineage for normal microglia development.
Brain Colonization of Microglia Is Disrupted in xpr1b
Mutants
Microglia derive from a subset of primitive macrophages that
migrate from the yolk sac into the brain, where they differentiate
as microglia during embryogenesis (Ginhoux et al., 2010; Herbo-
mel et al., 2001). To define the role of xpr1b during microglia
development, we analyzed themacrophage lineage from the for-
mation of primitive macrophages to differentiation of microglia
(1–5 dpf). The markers mfap4 (microfibrillar-associated proteinCell Re4; Zakrzewska et al., 2010) and mpeg1:EGFP (macrophage ex-
pressed gene 1; Ellett et al., 2011) are expressed in macro-
phages and microglia after they begin to differentiate at 60 hpf.
Using these markers, we detected no difference in the number
or distribution of macrophages up to 24 hpf (A.M.M., unpub-
lished data). At 2 dpf, however, the number of mpeg1:EGFP-
positive cells within the CNS (eye, midbrain, and hindbrain)
was slightly but significantly reduced in xpr1b mutants (Figures
2A and 2C). This reduction became more apparent as develop-
ment progressed, so that wild-type larvae had approximately
50 mpeg1:EGFP-positive microglia/per field of view at 4 dpf,
compared to only about 14 in xpr1bmutants (Figures 2A and 2C).
We sought to determine whether the reduction in microglia in
xpr1b mutants reflected an overall reduction of the precursor
macrophage population. In contrast to microglia, there was no
significant reduction in the number of mpeg1:EGFP-labeled
macrophages in non-CNS locations of the head of xpr1b mu-
tants at 2 dpf, 3 dpf, or 4 dpf (Figures 2A and 2D). Similarly,
the number and distribution of mpeg1:EGFP-labeled macro-
phages in the trunk region of mutant larvae remained compara-
ble to wild-type up to 4 dpf, although a slight reduction wasports 8, 1659–1667, September 25, 2014 ª2014 The Authors 1661
Figure 3. xpr1b Is Required for Differentia-
tion of Microglia and Langerhans Cells
(A) Representative z stack images of the head re-
gion of stable mpeg1:EGFP transgenic fish at 3
and 4 dpf. In wild-type heterozygous fish, macro-
phages display an array of morphologies from
rounded (arrows) tomultiple process-bearing cells
(arrowhead). In contrast, xpr1b mutants display a
more restricted array of morphologies.
(B and C) Graphs show the percentage of mpe-
g1:EGFP-positive cells that contain 0, 1, 2, 3, or 4
or more processes at 3 dpf (B) or 4 dpf (C) (3 dpf
siblings: n = 6, mutants n = 5; 4 dpf siblings: n = 4,
mutants n = 4).
(D and E) Representative z stacks of the superficial
layers of the trunk of wild-type heterozygous and
xpr1b mutant fish at 10 (D) and 21 dpf (E). Insets
show representative images of Langerhans cells.
(F) Graph shows the average number of Langer-
hans cells in the field of view in the area of the trunk
highlighted in the schematics.
Error bars showSEM. *p% 0.05, using paired two-
tailed Student’s t test (10 dpf siblings: n = 5, mu-
tants n = 6; 21 dpf siblings: n = 7, mutants n = 6).
Scale bar, 50 mm. See also Figure S4.detected in the mutants (Figures 2B and 2E). In vivo time-lapse
imaging of mpeg1:EGFP-labeled cells in the head showed that
mutant macrophages divide at a rate similar to their wild-type
counterparts (Figure S2; Movies S1 and S2), suggesting that
reduced proliferation may not explain the decrease in the
mutants. In addition, our in vivo time-lapse imaging analysis
and TUNEL staining experiments showed no indication of higher
cell death in mutant macrophages (Movies S1 and S2). Because
the number of mpeg1:EGFP-expressing cells is reduced in the
CNS of xpr1b mutants at 2 dpf, prior to the differentiation of mi-
croglia in the wild-type, and because no significant reduction in
peripheral macrophages was found at this stage, the foregoing
analyses suggest that migration and invasion of the brain by mi-
croglial precursors is reduced in xpr1b mutants.
The noncanonical NOD-like receptor nlrc3-like was recently
reported to suppress inflammatory activation of primitive mac-
rophages and to enable their migration and differentiation as
microglia (Shiau et al., 2013). We sought to determine whether
the migratory defect present in xpr1b mutants is related to that
of nlrc3-like mutants. Similarly to nlrc3-like mutants, xpr1b mu-
tants had higher than normal neutrophil numbers in the head.
xpr1b mutants, however, did not have an increase of circulating
neutrophils or increased levels of proinflammatory cytokines,
which are characteristic of nlrc3-like mutants (Figure S3).
Furthermore, Nlrc3-like expression did not rescue the microglia
defect in xpr1b mutants, nor did Xpr1b expression rescue
nlrc3-like mutants (Figure S3). These results provide evidence
that xpr1b and nlrc3-like function in distinct genetic pathways
that are essential for microglia formation in zebrafish.
xpr1bMutant Macrophages Have Abnormal Morphology
and Do Not Differentiate as Microglia
Although the number of microglial progenitors (macrophages
located in the CNS) is reduced in xpr1b mutants, time-lapse im-1662 Cell Reports 8, 1659–1667, September 25, 2014 ª2014 The Auaging revealed that some mpeg1:EGFP-expressing cells are
able to enter the brain parenchyma (Figure 2H; Movies S3 and
S4). However, expression of the microglia marker apoe (Herbo-
mel et al., 2001) was not observed in mutants at any stage exam-
ined (2.5 dpf, 5 dpf, and 10 dpf) (Figures 2G–2I). Furthermore, the
morphology of mpeg1:EGFP-labeled cells was abnormal in
xpr1b mutants. In xpr1b mutants at 3 dpf, about 72% of mpe-
g1:EGFP-labeled cells in the midbrain and hindbrain had no pro-
cesses, compared to only 42% in wild-type (Figures 3A–3C). At 4
dpf, themorphological difference is evenmore pronounced, with
the majority of cells having two or more processes in wild-type,
whereas more than 60% of cells in the mutant had no processes
(Figures 3A–C). These data indicate that xpr1b is required
both for microglial progenitors to colonize the brain and also
for these cells to differentiate into apoe-expressing, process-
bearing microglia.
Number of Langerhans Cells and Their Complexity Is
Affected in xpr1bMutants
The requirement of xpr1b for the differentiation of primitive
macrophages into microglia cells raised the possibility of this
gene having a broader role in the differentiation of other
specialized tissue macrophages. To examine this possibility,
we analyzed Langerhans cells, a population of tissue macro-
phages that reside in the skin. In wild-type, the mepg1:EGFP
transgene-labeled cells in the skin displayed many processes
at 10 dpf and 21 dpf, consistent with the previously character-
ized location and morphology of Langerhans cells at these
stages (Figures 3D and 3E) (Svahn et al., 2013). In xpr1b mu-
tants, the number of these mepg1:EGFP-positive cells was
reduced in the skin (Figure 3F), and the cells that were present
had fewer processes (Figure S4). These results indicate that
xpr1b is also essential for the normal development of Langer-
hans cells.thors
Figure 4. xpr1b Is Required for Normal Skeletal Development
(A) mCT-derived volumetric reconstructions of the neural (top) and hemal (bottom) 14th vertebral arches from a representative wild-type (n = 6), heterozygous
(n = 7), and mutant (n = 6) fish. xpr1bmutant fish have excess bone on the inner surface of the arch compared to wild-type and heterozygous fish, reducing the
overall aperture of the canal. Scale bar, 100 mm.
(B–G) Graphs showing quantified values for the vertebral arch defect depicted in (A). xpr1bmutant fish exhibit significant reductions in canal aperture (B and E)
with a concomitant increase in the total amount of bone as measured by bone volume (BV; C and F) and surface area (SA; D and G).
(H) Volumetric reconstructions of the 14th vertebral bodies from a representative wild-type, heterozygous, and mutant fish. xpr1bmutant vertebral bodies appear
larger than their wild-type and heterozygous siblings. Scale bar, 100 mm.
(I and J) Graphs depicting the significant increase in the total amount of bone present in mutant vertebrae as measured by BV (I) and SA (J). Error bars show SEM.
Statistical significance was determined by unpaired, two-tailed t tests (*p < 0.05, **p < 0.005, ***p < 5 3 104).
(K) Lateral view of wild-type (left panel) and xpr1b mutant (right panel) adult fish. Inset shows the presence of an ectopic vessel in xpr1b mutants (right panel,
arrowheads) that is absent in wild-type fish.
See also Figure S5.xpr1bMutants Have Impaired Bone Remodelling that Is
Indicative of Osteoclast Defects
xpr1b mutants can survive to adulthood, although in reduced
numbers compared to their siblings (Figure S5A). Furthermore,
xpr1bmutants were also smaller than their siblings at 50 dpf but
were able to continue growing (Figure S5B). Interestingly, some
xpr1b mutant adults (two out of nine) displayed severe abnor-
malities in their body axis. In light of such severe malformations
and reduced viability, we sought to determine whether Xpr1 is
important for bone architecture. Micro-computed tomography
(mCT) imaging revealed pronounced vertebral abnormalities in
xpr1b mutants. Notably, the 14th and 16th hemal canals were
about 10% of the wild-type size (Figures 4A and 4E; Figure S5).
The neural canals of the same vertebrae were less affected inCell Rethe mutants but still only about 40% of the wild-type size (Fig-
ures 4A and 4B; Figure S5). Likewise, xpr1b mutants had
greater bone volumes and surface areas than their siblings (Fig-
ures 4A, 4C, 4D, 4F and 4G; Figure S5). These results suggest
that in xpr1bmutants bone resorption is impaired. We extended
our analysis to determine if the vertebral bodies of the 14th and
16th vertebrae also displayed features consistent with a defect
in bone resorption. As with the vertebral arches, we found
that xpr1b mutant vertebrae had greater bone volumes (Figures
4H and 4I) and surface areas (Figures 4H and 4J) than their sib-
lings. These results are also consistent with a generalized
defect in bone resorption in xpr1b mutants. Osteoclasts are
cells derived from macrophages that have the primary function
of resorbing bone during remodelling, and mutations thatports 8, 1659–1667, September 25, 2014 ª2014 The Authors 1663
Figure 5. xpr1a Encodes a Functional
Phosphate Exporter but Is Not Required
for Microglia Development or Embryonic
Development
(A) Graphic representation of the domain structure
of Xpr1b and Xpr1a showing their shared identity.
(B) Graph representing the percentage of rescued
xpr1bmutants when xpr1b, controlmcherry (C), or
xpr1a are expressed in the macrophage lineage.
(C) Representative dorsal image of a neutral red-
stained 5 dpf xpr1b mutant larva rescued by
expression of xpr1a in the macrophage lineage.
(D) Top panel shows diagram depicting the TALE
nuclease targeted nucleotide sequence and the
corresponding amino acid sequence of xpr1a.
Bottom panels show the two alleles generated
that have frameshift mutations in xpr1a coding
sequence resulting in premature stop codons.
(E) Dorsal views of neutral red-stained 5 dpf xpr1a
mutant (left) and xpr1b;xpr1a double mutant (right)
show that xpr1amutants have a normal number of
microglia cells.
(F) Lateral views of neutral red-stained 5 dpf xpr1a
mutant (left) and xpr1b;xpr1a double mutant (right)
show grossly normal development at 5 dpf.
Scale bar, 50 mm.affect osteoclasts number and function disrupt bone remodel-
ling (Segovia-Silvestre et al., 2009). Indeed, the zebrafish
panther mutant, which has a mutation in the macrophage col-
ony-stimulating factor 1 receptor a (csf1ra), has a reduced num-
ber of osteoclasts and narrower neural and hemal canals due to
increased bone mass (Chatani et al., 2011). Interestingly, csfr1a
mutants also had impaired blood vessel formation, with the for-
mation of an ectopic blood vessel that bypassed the occluded
hemal canals. xpr1b mutants also had blood vessels in their
ventral regions that were not observed in their siblings (Fig-
ure 4K). The parallels between xpr1b and csfr1a mutant pheno-
types suggest that the skeletal defects in xpr1b mutants arise
from a reduction of osteoclast number or function. Taken
together, these phenotypic studies provide evidence that Xpr1
is essential for the development and function of diverse tissue
macrophage populations, including microglia, Langerhans cells,
and osteoclasts.
xpr1a, the Only Zebrafish Paralog of xpr1b, Is Not
Required for Microglia or Normal Embryonic
Development
The zebrafish genome contains a second XPR1 homolog, xpr1a.
Xpr1a shares 80% identity and 89% similarity with human XPR1
and 80% identity and 87% similarity with Xpr1b (Figure 5A). To
investigate the function of xpr1a, we used TALE nucleases to
generate mutations near the 50 end of xpr1a coding sequence
(Figure 5D). Homozygous mutants for two different frameshift
mutations in xpr1a (st91 and st92) had normal microglia develop-
ment and gross embryonic morphology (Figures 5E and 5F and
unpublished data). xpr1a homozygous mutants were viable as
adults. Additionally, xpr1b; xpr1a double mutants resembled
xpr1b single mutants, with reduced microglia but otherwise
normal morphology in the embryo and early larva. Despite the1664 Cell Reports 8, 1659–1667, September 25, 2014 ª2014 The Auevidence that XPR1 is the main phosphate exporter in meta-
zoans, our genetic studies indicate the function of Xpr1 is
required in specific cell types, including at least several macro-
phage lineages, and not broadly across all tissues.
Transgenic Expression of Xpr1a Rescues Microglia in
xpr1bMutants
To test if Xpr1a can functionally substitute for Xpr1b, we injected
the progeny of an xpr1b heterozygous intercross with a trans-
gene expressing xpr1a under the control of themacrophage line-
age promoter, mpeg1. Expression of Xpr1a in the macrophage
lineage rescued xpr1b mutants to similar levels as expression
of Xpr1b (63% rescue with Xpr1a [n = 27] versus 69% rescue
with Xpr1b [n = 20]; Figures 5B and 5C). Although zygotic
xpr1a is not required for normal development, these results indi-
cate that Xpr1a can fulfill the function of Xpr1b when expressed
in the macrophage lineage.
DISCUSSION
XPR1, initially identified as a receptor for xenotropic and poly-
tropic gamma retroviruses, is the only known phosphate
exporter in metazoans (Giovannini et al., 2013). This multipass
transmembrane protein is highly conserved across evolution,
and closely related proteins are present in species as diverse
as humans, plants, and unicellular eukaryotes. Previous anal-
ysis suggested that Xpr1 mediates phosphate export in a
wide range of vertebrate cell types (Giovannini et al., 2013),
but prior genetic studies did not analyze the role of Xpr1 in ver-
tebrates in vivo. Our genetic analysis in zebrafish provides
strong evidence that Xpr1b has a unique and specific function
in highly specialized tissue-resident macrophages, including
microglia and osteoclasts.thors
Phosphate Homeostasis and Tissue Specificity
In light of the functional conservation of Xpr1 homologs among
metazoans and in budding yeast, the cell-type specificity of
Xpr1b is remarkable. Complex regulatory mechanisms control
phosphate homeostasis in unicellular and multicellular organ-
isms. In the latter, Pi homeostasis occurs both at the cellular
and organismal level. Cellular phosphate influx largely relies on
the presence of sodium-dependent phosphate transporters
(Biber et al., 2013; Forster et al., 2013). Whereas some of these
transporters are ubiquitously expressed (e.g., SLC20A1 and
SLCA20A2), expression of others (e.g., SLC34) is almost exclu-
sively restricted to certain tissues with critical function in regu-
lating organismal phosphate levels, such as the small intestine
and kidney (Biber et al., 2013; Forster et al., 2013). The expres-
sion and activity of these transporters are regulated bymany fac-
tors to ensure that phosphate homeostasis is maintained.
The biochemical function of Xpr1 as a phosphate exporter was
only recently described (Giovannini et al., 2013), and the role of
phosphate exporters in organismal phosphate homeostasis re-
mains elusive. Our data suggest that Xpr1b is not required for
phosphate transport or other functions in most cell types but is
instead required in a specific subset of cells, including microglia,
Langerhans cells, and osteoclasts. Our analysis suggests that
the regulated activity of sodium-dependent phosphate trans-
porters is sufficient for proper phosphate balance in most cell
types and that the requirement for dedicated phosphate ex-
porters is restricted to cells that experience extreme phosphate
fluctuations. Such cells could include highly phagocytic cells,
including microglia, cells involved in phosphate (re)absorption
(e.g., small intestine enterocytes and proximal tubule cells),
and cells involved in bone resorption (osteoclasts). In fact, the
presence of a dedicated phosphate exporter has long been hy-
pothesized in epithelial renal cells and osteoclasts (Barac-Nieto
et al., 2002; Ito et al., 2007). In particular, osteoclasts were shown
to have a unique Pi efflux system, involved in the continuous
release of Pi at the basolateral plasma membrane preventing
accumulation of intracellular inorganic phosphate (Ito et al.,
2007). In assays of cultured mammalian cells, Xpr1 mediates
phosphate export (Giovannini et al., 2013), and our genetic
studies indicate that Xpr1b has an essential function in osteo-
clasts and other tissue macrophages in vivo. To explore the pos-
sibility that xpr1a, which encodes a protein 80% identical to
Xpr1b, might have functions overlapping with xpr1b, we used
transgenic and mutational approaches. As one might expect
from the extent of sequence similarity, our experiments indicate
that a transgene expressing Xpr1a in themacrophage lineage re-
stores microglia in xpr1b mutants. Nonetheless, xpr1a mutants
were phenotypically indistinguishable from their wild-type sib-
lings, and xpr1b:xpr1a double mutants were phenotypically
similar to xpr1b single mutants. Therefore, it seems that the zy-
gotic functions Xpr1b and Xpr1a are largely dispensable for the
early development of many cell types. It is important to note
that earlier functions, in and out of the macrophage lineage,
might be masked by the maternal expression of both these pro-
teins. Nevertheless, the double mutants survive for at least
20 days postfertilization, further supporting the possibility that
these phosphate exporters have cell-type-specific rather than
general functions.Cell ReXpr1b and Development of Tissue-Resident
Macrophages
The cytokine colony-stimulating factor 1 (CSF1), the interleukin
IL-34, and their receptor, colony-stimulating factor 1 receptor
(CSF1R), are key regulators of macrophage development (Da-
vies et al., 2013; Wynn et al., 2013). Studies in mice, rats, and
zebrafish have revealed a conserved role of the macrophage
colony-stimulating factor 1 receptor a (csfr1a aka fms) in the
establishment ofmany tissue-resident populations, includingmi-
croglia, osteoclasts, and Langerhans cells (Droin and Solary,
2010; Nakamichi et al., 2013). In zebrafish, csfr1a mutants
(panthermutants) have primitive macrophages, which proliferate
and move but fail to colonize the brain and other target tissues
(Herbomel et al., 2001). Similarly, migration of macrophages
into the brain is reduced in xpr1b mutants. In contrast to
csfr1a/panther mutants, in xpr1b mutants, the small number of
macrophages that are able to enter the brain parenchyma do
not differentiate into apoe-expressing microglia. In addition, in
xpr1b mutants, there is no recovery of the microglia population
as larval development begins, in contrast to csfr1a/panther
mutant larvae, which gain increasing numbers of microglia
as larval development progresses. csfr1a/panther and xpr1b
mutants also share an osteopetrotic phenotype, which appears
to be more severe in xpr1b mutants, as judged by the extent of
occlusion of the neural and hemal canals. Although we did not
experimentally address the autonomy of Xpr1b in Langerhans
cells and osteoclasts, we have shown that Xpr1b acts auto-
nomously in the macrophage lineage to rescue the microglia
phenotype. Because Langerhans and osteoclasts are also
derived in part from primitive macrophages (Ginhoux et al.,
2010; Hoeffel et al., 2012), it is likely that Xpr1b acts autono-
mously not only in microglia but also in these other tissue
macrophage populations. Further experiments are required to
determine if there is any relationship between xpr1b and csfr1a
signaling and to determine the mechanisms by which the loss
of the phosphate exporter disrupts the establishment of tissue
resident macrophage populations. It is also possible that XPR1
has other functions that are essential for development of tissue
macrophages, in addition to its activity as a phosphate exporter
(Giovannini et al., 2013; Wege and Poirier, 2014).
In summary, we show that the phosphate exporter Xpr1b acts
specifically and autonomously in the macrophage lineage. Our
analysis of xpr1a mutants and xpr1b;xpr1a double mutants
shows that the zygotic function of this phosphate exporter is
required only in specific cell types and not generally for devel-
opment and survival of the larva. Our xpr1a and xpr1b mutants
will be valuable in the analysis of the intricate regulation of
phosphate homeostasis at the cellular and organismal level
in vivo.
EXPERIMENTAL PROCEDURES
Zebrafish Lines and Embryos
Wild-type (TL, AB/TU, and WK), transgenic, and heterozygous xpr1b fish were
raised at 28.5C and staged as described previously (Kimmel et al., 1995). To
inhibit pigmentation, embryos were treated with 0.003% 1-phenyl-2-thiourea
(PTU) in methylene blue embryo water. The transgenic lines Tg(lyz:EGFP),
Tg(mpeg1:EGFP), and Tg(kdrl:mCherry-CAAX) have been previously
described (Hall et al., 2007; Ellett et al., 2011; Fujita et al., 2011). Experimentalports 8, 1659–1667, September 25, 2014 ª2014 The Authors 1665
protocols involving zebrafish were approved by the Stanford University Institu-
tional Animal Care and Use Committee.
ENU Mutagenesis, Microglia Screen, and Neutral Red Assay
Founder P0 wild-type males were mutagenized with ENU and subsequently
outcrossed to raise F1 and F2 families for screening as described previously
(Pogoda et al., 2006). An F3 genetic screen was conducted to identify putative
mutants with specific defects in microglia (e.g., loss of microglia) but no
apparent anatomical morphological defects at 5 dpf. Microglial cells were
scored in live 3–5 dpf larvae after treatment with the vital dye neutral red as
described previously (Shiau et al., 2013). Briefly, larvae were incubated in em-
bryo water containing 2.5 mg/ml neutral red at 28.5C for 2–3 hr, followed by
two water changes, and analyzed 4–24 hr later using a dissection microscope.
Genetic Mapping
st87 mutant embryos were separated from wild-type siblings based on the
neutral red phenotype, lack of microglia, at 5 dpf. Bulk segregant analysis
with 480 simple sequence-length polymorphisms (SSLPs) (Pogoda et al.,
2006) identified markers on LG2 flanking the st87 mutation. High-resolution
mapping was conducted using additional SSLPs and SNPs linked to the
mutation, which were found from sequencing PCR fragments amplified from
genomic DNA of mutants and wild-type siblings. Sequencing of PCR products
of genes in the critical interval identified st87 lesion in the xpr1b gene. st87
lesion was genotyped based on the PCR/restriction digest assay using the
forward primer (50-GCTGCTAACAGAATACTTCCT-30), reverse primer (50-
CCAGTCCCGGCTTGGACTCTGA-30), and digestion with DdeI.
Sequence-Specific TALE Nucleases
The 50 regions of xpr1b and xpr1a geneswere selected as targets. Theweb tool
TAL Effector-Nucleotide Targeter 2.0 (TALE-NT 2.0; https://tale-nt.cac.cornell.
edu) was used to design transcription activator-like effector nuclease (TALEN)
pairs and identify a diagnostic restriction enzyme. The specific sequence for
each TALEN is detailed in Table S1. TALEN assembly followed the PCR/
Golden Gate cloning protocol (Sanjana et al., 2012). TALE nuclease mRNA
was transcribed using the Sp6 mMessage mMachine kit (Ambion). A total of
400–800 pg of TALE nuclease mRNA was injected into one- to two-cell-stage
embryos, which were raised at 28.5C. Carriers of deletions in the xpr1b and
xpr1a genes were identified by PCR/restriction digest assay with the primers
present in Table S1 and the restriction enzymes FspI and Hpy188III. Stable
lines of two different alleles for each gene were established.
Whole-Mount In Situ Hybridization
In situ hybridization on whole zebrafish embryos and larvae was performed as
previously described (Pogoda et al., 2006). Antisense riboprobes were tran-
scribed for lyz, mfap4, apoe, and mpx as described previously (Shiau et al.,
2013).
Time-Lapse and Fluorescent Imaging
Embryos and larvae used for live imaging were treated with 0.016% (w/v)
tricaine, mounted in 1.5% low-melting-point agarose, and imaged at room
temperature. Images for determination of average number of mpeg1:EGFP-
positive cells were acquired on a Zeiss Axio Observer microscope coupled
to a Perkin Elmer UltraView vox spinning-disk confocal. Images of laterally
mounted embryos and larvae were captured with a Hamamatsu camera, us-
ing the Volocity Acquisition suite for multidimensional multichannel time-lapse
recording. Images were analyzed using Volocity software and processed with
Adobe Photoshop. All other imaging was done on a Zeiss LSM 5 Pascal
confocal microscope. Image J software was used to make maximum intensity
projections of z stacks, and images were processed for contrast and bright-
ness in Photoshop. The average number of Langerhans cells was determined
by counting the number of mpeg1:EGFP-positive cells present in the skin in
the field of view. Images were taken always from the region immediately pos-
terior to the anal fin. Analysis of the number of projections per cell was done
per field of view and in maximum-intensity projections obtained using ImageJ
software. Time-lapse imaging of mpeg1:EGFP; kdrl:mcherryCAAX transgenic
line was done by capturing one z stack per 20 s for 30 min, using the 203
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The coding sequences of xpr1b and xpr1bwere cloned from a 5 dpf embryonic
cDNA pool and directionally inserted into pCR8/GW/TOPO vector (Invitrogen);
primers used are in Table S1. For RNA expression, xpr1b sequence was subcl-
oned into the pCSDest vector using multsite GATEWAY technology (Kwan
et al., 2007). Tol2 sequence containing constructs used for tissue-specific
expression were also made using multisite GATEWAY (Kwan et al., 2007).
The tissue-specific regulatory sequences used have been reported elsewhere
(Shiau et al., 2013). Tissue-specific transgenes were transiently expressed by
coinjecting 12–25 pg of Tol2-plasmids described above and 100–200 pg of
Tol2 transposase mRNA into one-cell embryos.
Bone-Remodeling Phenotypes
Wild-type (xpr1b+/+, n = 6), heterozygous (xpr1bst87/+ and xpr1bst89/+, n = 3 and
n = 4, respectively), and mutant fish (xpr1bst87/st89, n = 6) were collected when
their standard length was 2.5 cm, fixed in 4% paraformaldehyde for 24 hr, and
rinsed in 13 PBS. Skeletal phenotypes were evaluated by mCT. Fish were
scanned in 13 PBS using a Scanco mCT40 operated at 70 kVp, 114 mA, at me-
dium resolution, andwith 23 averaging. Voxel size was 12 mm3 for all fish. Eval-
uation of the 14th and 16th vertebral arches was performed on an average of 63
(hemal) and 65 (neural) 2D slices (750–780 mm) beginning at the anterior edge
of each arch. Volumetric reconstruction images were imported into Adobe
Photoshop and measured to determine the average canal aperture for each
genotypic class (defined as the total number of pixels corresponding to the
arch opening). Bone volume (direct) and surface area (TRI-plate model) mea-
surements were evaluated using Scanco/OpenVMS software. Characteriza-
tion of vertebral body defects of the 14th and 16th vertebrae was performed
by evaluation of an average of 53 2D slices (640 mm) beginning at the anterior
edge of each vertebra. Bone volume and surface area measurements were
determined as above. Statistical significance of all measurements was deter-
mined by unpaired, two-tailed t tests.
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